Cook celect vena cava filter (Cook Medical Inc.) for prophylaxis and treatment of pulmonary embolism

Record ID 32012000591
English
Authors' recommendations: Venous thromboembolism (VTE), the formation of blood clots in veins, is a leading cause of disability and death. The syndrome refers to both deep vein thrombosis (DVT) and pulmonary embolism (PE). Each year an estimated 300,000 to 600,000 people in the United States are affected by VTE (1 to 2 per 1000) and of these, approximately 50,000 to 100,000 die from complications due to PE. PE is the leading cause of preventable in-hospital mortality in the United States, accounting for 5% to 10% of deaths in hospitalized patients. Usual care for treatment of VTE is systemic anticoagulation; patients diagnosed with DVT or PE receive initial anticoagulation in the acute setting with therapeutic subcutaneous low-molecular-weight heparin or intravenous heparin drip, and are then transitioned to warfarin. However, anticoagulation therapy entails a risk of bleeding and other complications, and some patients fail therapy or have contraindications to anticoagulants. As an alternative to anticoagulation and other techniques for preventing PE in patients with VTE, vena cava filters, or specifically, inferior vena cava (IVC) filters, were introduced in the 1970s, which trap emboli that pass from the iliofemoral system through the IVC. However, potential complications of the early filters such as IVC thrombosis led to the development of removable filters designed for easier retrieval. The introduction of these retrievable filters, also known as optional or temporary filters, has expanded the clinical indications for these devices.
Details
Project Status: Completed
Year Published: 2012
English language abstract: An English language summary is available
Publication Type: Not Assigned
Country: United States
MeSH Terms
  • Vena Cava Filters
Contact
Organisation Name: HAYES, Inc.
Contact Address: 157 S. Broad Street, Suite 200, Lansdale, PA 19446, USA. Tel: 215 855 0615; Fax: 215 855 5218
Contact Name: saleinfo@hayesinc.com
Contact Email: saleinfo@hayesinc.com
Copyright: 2012 Winifred S. Hayes, Inc
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.